Tyra Biosciences (TYRA) Non Operating Income (2020 - 2026)

Tyra Biosciences has reported Non Operating Income for 7 years, with the latest figure at $2.7 million in Q1 2026.

• For the quarter ending Q1 2026, Non Operating Income fell 27.28% year-over-year to $2.7 million; the trailing twelve-month figure through Mar 2026 stood at $11.8 million (down 31.74% YoY), and the FY2025 full-year result was $12.8 million, down 27.58% from the prior year.
• Non Operating Income for Q1 2026 stood at $2.7 million, roughly flat from $2.7 million in the prior quarter.
• The five-year high for Non Operating Income was $4.8 million in Q2 2024, with the low at $5000.0 in Q3 2022.
• Historically, Non Operating Income has averaged $2.7 million across 5 years, with a median of $2.8 million in 2023.
• Annual changes were most pronounced in 2022 — Non Operating Income surged 106050.0% — and 2025, when it slumped 35.73%.
• Tyra Biosciences' Non Operating Income stood at $2.1 million in 2022, then jumped by 32.08% to $2.8 million in 2023, then jumped by 48.82% to $4.2 million in 2024, then tumbled by 35.73% to $2.7 million in 2025, then grew by 0.41% to $2.7 million in 2026.
• The last three Non Operating Income figures came in at $2.7 million (Q1 2026), $2.7 million (Q4 2025), and $3.1 million (Q3 2025), per Business Quant data.